DK1229936T3 - Use of anti-idiotypic antibodies as vaccines against cancer - Google Patents

Use of anti-idiotypic antibodies as vaccines against cancer

Info

Publication number
DK1229936T3
DK1229936T3 DK00987250T DK00987250T DK1229936T3 DK 1229936 T3 DK1229936 T3 DK 1229936T3 DK 00987250 T DK00987250 T DK 00987250T DK 00987250 T DK00987250 T DK 00987250T DK 1229936 T3 DK1229936 T3 DK 1229936T3
Authority
DK
Denmark
Prior art keywords
against cancer
idiotypic antibodies
vaccines against
vaccines
idiotypic
Prior art date
Application number
DK00987250T
Other languages
Danish (da)
Inventor
Hans Loibner
Helmut Eckert
Gottfried Himmler
Original Assignee
Igeneon Krebs Immuntherapie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs Immuntherapie filed Critical Igeneon Krebs Immuntherapie
Application granted granted Critical
Publication of DK1229936T3 publication Critical patent/DK1229936T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
DK00987250T 1999-11-16 2000-11-15 Use of anti-idiotypic antibodies as vaccines against cancer DK1229936T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0192799A AT409086B (en) 1999-11-16 1999-11-16 NEW USE OF ANTIBODIES AS VACCINE

Publications (1)

Publication Number Publication Date
DK1229936T3 true DK1229936T3 (en) 2004-08-30

Family

ID=3524036

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00987250T DK1229936T3 (en) 1999-11-16 2000-11-15 Use of anti-idiotypic antibodies as vaccines against cancer

Country Status (24)

Country Link
EP (1) EP1229936B1 (en)
JP (1) JP2003514028A (en)
KR (1) KR20020060968A (en)
CN (1) CN1390138A (en)
AT (1) AT409086B (en)
AU (1) AU780853B2 (en)
BR (1) BR0015597A (en)
CA (1) CA2391927A1 (en)
CZ (1) CZ20021707A3 (en)
DE (1) DE50006526D1 (en)
DK (1) DK1229936T3 (en)
EE (1) EE200200252A (en)
ES (1) ES2218272T3 (en)
HU (1) HUP0204216A2 (en)
IL (1) IL149614A0 (en)
IS (1) IS6381A (en)
MX (1) MXPA02004942A (en)
NO (1) NO20022333L (en)
NZ (1) NZ518669A (en)
PL (1) PL356770A1 (en)
PT (1) PT1229936E (en)
SK (1) SK6542002A3 (en)
TR (1) TR200401267T4 (en)
WO (1) WO2001035989A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017108A (en) * 1975-04-17 1977-04-12 Archibald Kenrick And Sons Limited Window stay
US6294171B2 (en) * 1999-09-14 2001-09-25 Milkhaus Laboratory, Inc. Methods for treating disease states comprising administration of low levels of antibodies
AT410172B (en) 2000-03-21 2003-02-25 Igeneon Gmbh METHOD FOR PRODUCING VACCINE FORMULATION
AT410637B (en) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie USE OF POLYCLONAL IMMUNOGLOBULINES
AT502293B1 (en) * 2002-05-15 2008-03-15 Igeneon Krebs Immuntherapie IMMUNOGENERAL, MONOCLONAL ANTIBODY
AT500648B1 (en) * 2002-08-12 2010-03-15 Igeneon Krebs Immuntherapie SET FOR THE TREATMENT OF CANCER PATIENTS
KR100522526B1 (en) * 2002-11-28 2005-10-19 주식회사 바이넥스 Method of Preparing Dendritic cell for Immunotherapy
AT500650B1 (en) * 2003-04-17 2009-11-15 Altropus Gmbh IMMUNOGENIC RECOMBINANT ANTIBODY
WO2007024825A2 (en) * 2005-08-26 2007-03-01 Genway Biotech, Inc. Immunoaffinity separation and analysis compositions and methods
EP2044949A1 (en) 2007-10-05 2009-04-08 Immutep Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
GB201322626D0 (en) 2013-12-19 2014-02-05 Immutep S A Combined preparations for the treatment of cancer
US20180008702A1 (en) * 2014-12-05 2018-01-11 Celltrion Inc. Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same
GB201500374D0 (en) 2015-01-09 2015-02-25 Immutep S A Combined preparations for the treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135536A1 (en) * 1983-01-28 1985-04-03 Centocor, Inc. Anti-idiotypic antibodies to t cell antigen receptors
ATE115412T1 (en) * 1988-05-17 1994-12-15 Soldano Ferrone ANTI-IDIOTYPE ANTIBODIES AGAINST ANTI-HUMAN HIGH MOLECULAR ANTIGENS ASSOCIATED WITH MELANOMA.
US20030072751A1 (en) * 1990-03-14 2003-04-17 Heribert Bohlen Idiotypic vaccination against b cell lymphoma
IT1254315B (en) * 1992-03-27 1995-09-14 Mini Ricerca Scient Tecnolog ANTI-IDIOTYPIC MONOCLONAL ANTIBODIES DIRECT AGAINST ANTI-TNF ANTIBODIES.
AU4662393A (en) * 1992-07-08 1994-01-31 Schering Corporation Use of gm-csf as a vaccine adjuvant
CA2209360C (en) * 1994-12-28 2010-07-06 University Of Kentucky Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen

Also Published As

Publication number Publication date
SK6542002A3 (en) 2002-11-06
CN1390138A (en) 2003-01-08
EE200200252A (en) 2003-06-16
PT1229936E (en) 2004-09-30
NO20022333L (en) 2002-06-03
TR200401267T4 (en) 2004-07-21
ES2218272T3 (en) 2004-11-16
MXPA02004942A (en) 2003-10-14
PL356770A1 (en) 2004-07-12
NZ518669A (en) 2003-08-29
CA2391927A1 (en) 2001-05-25
KR20020060968A (en) 2002-07-19
NO20022333D0 (en) 2002-05-15
ATA192799A (en) 2001-10-15
CZ20021707A3 (en) 2002-10-16
HUP0204216A2 (en) 2003-04-28
AU780853B2 (en) 2005-04-21
WO2001035989A2 (en) 2001-05-25
EP1229936A2 (en) 2002-08-14
IL149614A0 (en) 2002-11-10
AU2357201A (en) 2001-05-30
IS6381A (en) 2002-05-14
WO2001035989A3 (en) 2001-10-04
AT409086B (en) 2002-05-27
DE50006526D1 (en) 2004-06-24
BR0015597A (en) 2002-07-23
EP1229936B1 (en) 2004-05-19
JP2003514028A (en) 2003-04-15

Similar Documents

Publication Publication Date Title
PT1210113E (en) COMPOUNDS OF COMBINATION VACCINES
ATE490327T1 (en) VACCINE COMPOSITION
NO20014325D0 (en) Vaccine
DK1326638T3 (en) Vaccines against cancer
DE50007817D1 (en) MICROMIRROR
DE69932650D1 (en) cementing
DK1390066T3 (en) vaccine Composition
DE60033715D1 (en) Servo-controller
DK1139764T3 (en) adjuvant
DE60002650D1 (en) Oil-vaccinated vaccine
NO20020763L (en) Vaccine
DK1176964T3 (en) Use of ET743 for the treatment of cancer
ITMI991658A0 (en) PROCEDURE FOR THE PREPARATION OF EPOXIDES
DK1229936T3 (en) Use of anti-idiotypic antibodies as vaccines against cancer
DE60043058D1 (en) DENTAL MATERIALS
DK1350521T3 (en) Immunotherapeutic combinations for the treatment of tumors
DE60129876D1 (en) Optical tomograph
DK1311267T3 (en) RETROVIRAL IMMUNOTHERAPY
DE60044696D1 (en) lipstick
DK1180041T4 (en) Vaccine against ISA virus
NO20014845D0 (en) Use of arylalkanoylpyridazines
DE10294532D2 (en) Artificial lymph node
ITMI20002086A0 (en) GLUEING PROCEDURE
DK199900092U3 (en) Tiling
DE29904286U1 (en) Optical tomograph